Connect Biopharma (NASDAQ:CNTB) shared new clinical and preclinical updates on rademikibart, its IL-4 receptor alpha ...

The FDA has ramped up the pressure on Amgen to withdraw Tavneos for a rare vasculitis condition from the market, with a ...

Top-line results from the OBERON and TITANIA trials showed that tozorakimab reduced the annualised rate of moderate-to-severe ...

Friday's positive trial results for tozorakimab mark a significant inflexion point for AstraZeneca PLC (LSE:AZN, NASDAQ:AZN), ...

GSK’s Exdensur receives China NMPA approval for the treatment of severe asthma: London, UK Tuesday, March 31, 2026, 09:00 Hrs [IST] GSK plc, a global biopharma company, announce ...

Exposure to dupilumab is associated with an increased risk of being diagnosed with cutaneous autoimmune diseases in children ...

AstraZeneca PLC (NYSE:AZN) is one of the best pharma stocks to invest in now. AstraZeneca PLC (NYSE:AZN) received a rating ...

Probability of Remaining Event-Free at 24 Months by Kaplan-Meier Analysis After Achieving Complete Response at Three Months ...

Kaitlyn Rose Laura, 30, is accused of forcing her son to use a wheelchair and getting him unnecessary feeding tubes.

Positive high-level results from the Phase III OBERON and TITANIA trials in patients with chronic obstructive pulmonary ...

The treatment, tozorakimab, succeeded where other similar therapies failed and could help a broader group of COPD patients ...

Trevi Therapeutics Investor and Analyst Day May 7, 2026, Midtown New York, New York 10:00 a.m. to 12:00 p.m. ET Representatives: Trevi senior management will be joined by key opinion leaders in ...